The ability of bacteria to survive or grow despite exposure to an antibiotic that would normally kill them or stop their growth

Resistance is a property of bacteria (or their genes), not of the human body

Antibiotic tolerance

Persistence

Multidrug resistance (MDR)

Extensive drug resistance (XDR) / Pandrug resistance (PDR)

Cell wall synthesis (e.g., β-lactams)

Protein synthesis (ribosomes; e.g., macrolides, aminoglycosides, tetracyclines)

DNA replication/repair (e.g., fluoroquinolones)

RNA synthesis (e.g., rifamycins)

Metabolic pathways (e.g., folate synthesis inhibitors)

Antibiotics kill susceptible bacteria, leaving survivors to reproduce and spread

Mutations

Horizontal gene transfer (HGT)

Enzymatic inactivation of the antibiotic

Alteration of the drug target

Reduced drug entry (decreased permeability)

Increased drug efflux (pumping the drug out)

Bypassing the blocked pathway

Biofilms and community protection

Incomplete killing allows resistant survivors to expand

Suboptimal dosing or early stopping increases survival chances

Person-to-person spread in communities

Hospital transmission via surfaces, devices, and healthcare contact

Spread through food, water, and animals

Human microbiome as a gene reservoir (“resistome”)

Animal agriculture and aquaculture environments

Wastewater and environmental contamination with antibiotic residues and resistant bacteria

Intensive care units and long-term care facilities

Areas with limited infection control resources

Regions with over-the-counter or unregulated antibiotic access

Taking antibiotics for viral infections (e.g., colds, flu)

Using broad-spectrum drugs when narrow-spectrum would suffice

Unnecessary prophylactic prescriptions

Not completing prescribed courses when indicated

Wrong dose or schedule leading to inadequate drug exposure

Sharing leftover antibiotics or using expired medications

Limited rapid diagnostics leading to empirical broad-spectrum therapy

Time pressure and patient expectations

Poor antimicrobial stewardship programs

Routine use for growth promotion or disease prevention in crowded conditions

Mass medication of herds/flocks creating large-scale selection pressure

Pharmaceutical manufacturing discharge with antibiotic residues

Improper disposal of medications

Wastewater treatment limitations that allow resistant organisms to persist

Travel and trade moving resistant strains across borders rapidly

Common infections become harder to cure

Delays in effective therapy increase complications and mortality

Longer hospital stays and more intensive care needs

Need for expensive or toxic last-line antibiotics

More diagnostic testing and isolation measures

Undermines safety of procedures that rely on effective antibiotics

Rapid hospital outbreaks of resistant organisms

Limited outbreak control when few drugs remain effective

Higher risk where sanitation, vaccination, and healthcare access are limited

Greater mortality when second-line drugs are unavailable or unaffordable

Fewer new antibiotics developed due to scientific and economic hurdles

Resistance can emerge quickly even to new agents

Skin/soft tissue infections, pneumonia, bloodstream infections

Hospital-acquired infections, bloodstream/urinary infections

Resistant to many penicillins/cephalosporins; common in UTIs and sepsis

Often resistant to multiple classes; associated with high mortality

Long, complex treatment; major public health challenge

Common in ventilator-associated and wound infections

Culture-based tests (MIC, disk diffusion) to determine effective drugs

Molecular tests for resistance genes (rapid but gene-limited)

Hospital antibiograms guiding local prescribing

Regional/national reporting to track trends and outbreaks

Rising failure rates for standard therapies

Increasing need for last-line agents

Clusters of resistant infections in wards or communities

Use antibiotics only when prescribed by qualified clinicians

Follow dosing instructions precisely; do not share antibiotics

Keep vaccinations up to date to prevent infections that require antibiotics

Practice hygiene (handwashing, safe food handling) to reduce infection spread

Antimicrobial stewardship

Infection prevention and control

Rapid diagnostics

Regulation of antibiotic sales and prescription practices

Stewardship in agriculture (restrict routine use; improve animal husbandry)

Improve water, sanitation, and hygiene (WASH) infrastructure

Expand vaccination programs to lower antibiotic demand

Strengthen surveillance and outbreak response capacity

New antibiotics and combination therapies

Alternative approaches

Better diagnostics and point-of-care testing

Economic incentives to support antibiotic development while preventing overuse